The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts.
You must be a subscriber to access all of this content.
Learn about workplace mental health and the pressing need for companies to tackle stress and anxiety at work.
You must be a subscriber to access all of this content.
The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.
You must be a subscriber to access all of this content.
South Africa's Suicide Rate hits 21.1 per 100,000. New warnings highlight a rising burden, big productivity losses, and policy action.
You must be a subscriber to access all of this content.
Dis-Chem Franchise Expansion accelerates as the group targets 500 independent pharmacy conversions to boost market share.
You must be a subscriber to access all of this content.